Back to results
US 2025/0144028 A1Published application
Lipids and lipid nanoparticle formulations
AssigneeLonguide Biopharma Corporation
InventorsLonggui ZHANG, Yuebao ZHANG, Chen LIU, Xiuting XU, Yan WANG, Meigui LIANG, Yuanyuan XU, Wenting SONG, Zehao LIAO, Qinying ZHU, Yingxin LU
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to lipids, lipid nanoparticle formulations, and methods of using the same for delivering nucleic acids, such as mRNA.
Claims50
A compound of Formula I-1:
- wherein:
- L1 is C1-10 alkylene or C2-10 heteroalkylene;
- wherein the C2-10 heteroalkylene is optionally substituted with R6;
- L2 is C1-10 alkylene or C2-10 heteroalkylene;
- wherein the C2-10 heteroalkylene is optionally substituted with R6;
- X is —CH2—, —NR3—, —N(R3)2+—, —O—, —O—CH2CH2—O—, or —NR3—(CH2)m—NR3—;
- m is an integer from 1 to 6;
- R1, R2, and R3 are each independently hydrogen, C1-20 alkyl, C2-20 alkenyl, C2-20 alkynyl, C2-20 heteroalkyl,
- wherein the C1-20 alkyl, C2-20 alkenyl, C2-20 alkynyl, or C2-20 heteroalkyl is independently optionally substituted with one to five halo, cyano, —OR4, —SR4, —NR42, —N(R4)3+, oxo, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, or C1-6 haloalkyl;
- each Ra is independently hydrogen, C1-12 alkyl, or —C(O)—C1-12 alkyl;
- each R4 is independently hydrogen, C1-12 alkyl, C2-12 alkenyl, or C2-12 alkynyl;
- wherein each C1-12 alkyl, C2-12 alkenyl, or C2-12 alkynyl is independently optionally substituted with one to five halo, cyano, —OH, —SR5, —NR52, —N(R5)3+, or oxo;
- each R5 is independently hydrogen, C1-12 alkyl, C2-12 alkenyl, or C2-12 alkynyl;
- wherein each C1-12 alkyl, C2-12 alkenyl, or C2-12 alkynyl is independently optionally substituted with one to five halo, cyano, —OH, —SH, —NH2, —NH(C1-6 alkyl), —N(C1-6 alkyl)2, —N(C1-6 alkyl)3+, or oxo;
- each R6 is independently
- each L is independently C1-10 alkylene or C3-10 heteroalkylene;
- each Y is independently —O— or —NR7—;
- each R7 is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, or C1-6 haloalkyl;
- wherein each C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, or C1-6 haloalkyl is independently optionally substituted with one to five halo, cyano, —OH, —NH2, —NH(C1-6 alkyl), —N(C1-6 alkyl)2, —N(C1-6 alkyl)3+, oxo, C1-6 alkoxy, or C1-6 haloalkoxy;
- each n is independently an integer from 1-20;
- each R is independently hydrogen, —Z—C1-20 alkyl, —Z—C2-20 alkenyl, —Z—C2-20 alkynyl, —Z-heterocyclyl, —Z1—C1-6 alkylene-Z—C1-20 alkyl, —Z1—C1-6 alkylene-Z—C2-20 alkenyl, —Z1—C1-6 alkylene-Z—C2-20 alkynyl, —Z1—C1-6 alkylene-Z-heterocyclyl, —Z1—C2-6 alkenyl-Z—C1-20 alkyl, —Z1—C2-6 alkenyl-Z—C2-20 alkenyl, —Z1—C2-6 alkenyl-Z—C2-20 alkynyl, —Z1—C2-6 alkynyl-Z—C1-20 alkyl, —Z1—C2-6 alkynyl-Z—C2-20 alkenyl, or —Z1—C2-6 alkynyl-Z—C2-20 alkynyl;
- each Z is independently a bond, —O—, —NR4—, —S—, —S—S—, —C(O)—, —C(O)O—, —OC(O)—, —C(O)NR4—, —S(O)—, —S(O)2—, —NR4C(O)—, —NR4C(O)O—, —NR4C(O)NR4—, —NR4S(O)—, or —S(O)2NR4—;
- and
- each Z1 is independently —O—, —NR4—, —S—, —S—S—, —C(O)—, —C(O)O—, —C(O)NR4—, —S(O)—, —S(O)2—, —NR4C(O)—, —NR4C(O)O—, —NR4C(O)NR4—, —NR4S(O)—, or —S(O)2NR4—;
- provided that each
- moiety comprises at least 6 linear atoms.
23 more elements
A compound selected from Table 1A.
Dependencies are inferred from the claim text.